Published in Folia Histochem Cytobiol on January 01, 2009
Toll-like receptor 4 activation in cancer progression and therapy. Clin Dev Immunol (2011) 1.14
Overexpression of miR -155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3. PLoS One (2013) 0.99
Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers. Onco Targets Ther (2013) 0.94
Ischemic Preconditioning-Induced SOCS-1 Protects Rat Intestinal Ischemia Reperfusion Injury via Degradation of TRAF6. Dig Dis Sci (2016) 0.84
TNF receptor-associated factor 6 in advanced non-small cell lung cancer: clinical and prognostic implications. J Cancer Res Clin Oncol (2012) 0.83
Brucella spp. Lumazine Synthase Induces a TLR4-Mediated Protective Response against B16 Melanoma in Mice. PLoS One (2015) 0.77
Thiosulfate in urine as a facilitator in the diagnosis of prostate cancer for patients with prostate-specific antigen less or equal 10 ng/mL. Clin Chem Lab Med (2013) 1.44
Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers. Pathol Oncol Res (2012) 1.35
Gene expression of O-GlcNAc cycling enzymes in human breast cancers. Clin Exp Med (2011) 1.10
Androgen receptor status in female breast cancer: RT-PCR and Western blot studies. J Cancer Res Clin Oncol (2001) 0.93
Prediction of bladder cancer based on urinary content of MGEA5 and OGT mRNA level. Clin Lab (2012) 0.92
RAD51 genotype and triple-negative breast cancer (TNBC) risk in Polish women. Pol J Pathol (2013) 0.90
Association between the c.*229C>T polymorphism of the topoisomerase IIβ binding protein 1 (TopBP1) gene and breast cancer. Mol Biol Rep (2013) 0.89
Concentration of cadmium, nickel and aluminium in female breast cancer. Pol J Pathol (2011) 0.87
TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas. Gynecol Oncol (2004) 0.85
Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma. Int J Colorectal Dis (2007) 0.85
Relationship of urinary isoprostanes to prostate cancer occurrence. Mol Cell Biochem (2012) 0.84
Diagnostic value of DNA alteration: loss of heterozygosity or allelic imbalance-promising for molecular staging of prostate cancers. Med Oncol (2013) 0.83
Genetic polymorphism of metallothionein 2A and risk of laryngeal cancer in a Polish population. Med Oncol (2014) 0.82
Single nucleotide polymorphism (SNP) Thr241Met in the XRCC3 gene and breast cancer risk in Polish women. Pol J Pathol (2012) 0.81
Loss of heterozygosity and microsatellite instability at RAD52 and RAD54 loci in breast cancer. Pol J Pathol (2006) 0.81
Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer. Clin Exp Med (2012) 0.81
Expression of erbB-1 and erbB-2 genes in normal and pathological human endometrium. Oncol Rep (2007) 0.81
Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome. J Pharm Pharmacol (2014) 0.81
Effect of metallothionein 2A gene polymorphism on allele-specific gene expression and metal content in prostate cancer. Toxicol Appl Pharmacol (2013) 0.80
A multi-faceted analysis of RutD reveals a novel family of α/β hydrolases. Proteins (2012) 0.80
The c.469+46_56del mutation in the homeobox MSX1 gene--a novel risk factor in breast cancer? Cancer Epidemiol (2010) 0.80
Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse model of inflammatory bowel diseases. J Pharmacol Exp Ther (2013) 0.80
Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II. Folia Histochem Cytobiol (2011) 0.79
Expression of genes encoding for enzymes associated with O-GlcNAcylation in endometrial carcinomas: clinicopathologic correlations. Ginekol Pol (2012) 0.79
CC chemokines and chemokine receptors in IgA nephropathy (IgAN) and in non-IgA mesangial proliferative glomerulonephritis (MesProGN). the immunohistochemical comparative study. Pol J Pathol (2005) 0.79
[Quality of life in patients with laryngeal carcinoma after radical neck dissection]. Otolaryngol Pol (2003) 0.78
Molecular basis of taste sense: involvement of GPCR receptors. Crit Rev Food Sci Nutr (2014) 0.78
The inhibitory effect of diarylpropionitrile, a selective agonist of estrogen receptor beta, on the growth of MC38 colon cancer line. Cancer Lett (2008) 0.78
The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I. Folia Histochem Cytobiol (2011) 0.78
Genotyping of p53 codon 175 in colorectal cancer. Med Sci Monit (2003) 0.78
Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer. Pathol Int (2008) 0.78
Impact of EGFR immunoexpression on STAT3 activation and association with proinflammatory/regulatory cytokine pattern in laryngeal squamous cell carcinoma. Oncol Rep (2009) 0.78
TGFβ-pathway is down-regulated in a uterine carcinosarcoma: a case study. Pathol Res Pract (2013) 0.78
Topoisomerase IIβ binding protein 1 c.*229C>T (rs115160714) gene polymorphism and endometrial cancer risk. Pathol Oncol Res (2013) 0.78
Expression of TGF-beta type I and II receptors in normal and cancerous human endometrium. Cancer Lett (2002) 0.77
Immunoexpression of beta-catenin--E-cadherin complex in primary serous ovarian tumors. Pol J Pathol (2008) 0.77
Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis. Pol J Pathol (2005) 0.77
[Molecular basis of gynecological oncology--TopBP1 protein and its participation in the transcription process]. Ginekol Pol (2012) 0.77
The potential role of O-GlcNAc modification in cancer epigenetics. Cell Mol Biol Lett (2014) 0.77
Immunohistochemical expression of progesterone and estrogen receptors in meningiomas. Folia Neuropathol (2006) 0.77
Alterations of Chk1 and Chk2 expression in colon cancer. Int J Colorectal Dis (2008) 0.77
Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome. Pol J Pathol (2006) 0.76
Expression of endoglin in primary endometrial cancer. Oncology (2011) 0.76
[Correlation of membrane type I matrix metalloproteinase (MT1-MMP) expression with clinicomorphological features of tumor front in squamous cell carcinoma of the larynx]. Pol Merkur Lekarski (2007) 0.76
[Analysis of HIF-1α and COX-2 expression in tumor stroma and correlation with the degree of neoplasm invasiveness in laryngeal cancer--preliminary study]. Otolaryngol Pol (2011) 0.76
Posthatching developmental changes in noradrenaline content in the chicken pineal gland. J Pineal Res (2005) 0.76
Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms. Oncol Rep (2004) 0.76
[Cytokeratin antigen expression in lymph nodes--prognostic significance of clinical features of the primary tumor and lymph nodes in the presence of micrometastases in laryngeal carcinoma]. Przegl Lek (2006) 0.75
[Clinico-histopathological characteristic of inverted papilloma of nasal cavity and paranasal sinuses cases treated in Department of Laryngological Oncology UM of Lodz between 2002-2006--review of latest literature]. Otolaryngol Pol (2007) 0.75
[Expression of Foxp3 and RORgamma t in peripheral blood mononuclear cells in patients with laryngeal carcinoma as indicators of tumor stage--preliminary study]. Otolaryngol Pol (2011) 0.75
EGFR immunoexpression and peripheral blood cytokine secretion as potential biomarkers of tumor behavior in laryngeal squamous cell carcinoma. Med Sci Monit (2009) 0.75
[Diagnostic and prognostic values of repair protein hMLH1, hMSH2 and protein CD34 immunoexpression in sporadic colorectal cancer]. Pol Merkur Lekarski (2010) 0.75
Elicitation of contact hypersensitivity after repeated suberythemal exposures of humans to solar simulated radiation: number of epidermal Langerhans cells. Contact Dermatitis (2007) 0.75
[Production of cytokines by peripheral blood mononuclear cells--correlation with clinicomorphological features in laryngeal carcinoma]. Otolaryngol Pol (2008) 0.75
Immunoexpression of CAS protein is augmented in high grade serous ovarian tumors. Pol J Pathol (2010) 0.75
[Expression of activation antigens on the lymphocytes T in patients with carcinoma of the larynx and connection with tumor features]. Otolaryngol Pol (2008) 0.75
Suppression of contact hypersensitivity after repeated exposures of humans to low doses of solar simulated radiation. Photochem Photobiol Sci (2005) 0.75
[Morphological tumor front grading and matrix metalloproteinases type I expression as a prognostic parameter of the presence of lymph node micrometastases in laryngeal carcinoma]. Otolaryngol Pol (2007) 0.75
[Effects of metformin on the survival of the SKOV-3 ovarian cancer cell line and the expression of genes encoding enzymes involved in O-Glcnacylation]. Ginekol Pol (2014) 0.75
[Palatine tonsils colonization with actinomyces species during chronic tonsillitis]. Otolaryngol Pol (2006) 0.75
Why a Combination of WP 631 and Epo B is an Improvement on the Drugs Singly - Involvement in the Cell Cycle and Mitotic Slippage. Asian Pac J Cancer Prev (2016) 0.75
[Prognostic significance of clinical and morphological features of the lymph nodes in the presence of micrometastases--cytokeratin antigens expression in lymph nodes in laryngeal carcinoma]. Pol Merkur Lekarski (2005) 0.75
[Production of proinflammatory cytokines by peripheral blood mononuclear cells in cocultures with squamous cell carcinoma of the larynx]. Otolaryngol Pol (2009) 0.75
[Expression of transcription nuclear factor NFkappaB in laryngeal carcinoma tumor cells--correlation with IL-10 expression by blood mononuclear cells and clinicomorphological features]. Otolaryngol Pol (2009) 0.75
[Prognostic significance of morphological features of the tumor front in the presence of micrometastases in laryngeal carcinoma--cytokeration antigens expression in lymph nodes]. Otolaryngol Pol (2005) 0.75
Genetic instability in the RAD51 and BRCA1 regions in breast cancer. Cell Mol Biol Lett (2006) 0.75
Histological examination in assessment of ultraviolet-induced suppression of contact hypersensitivity response. Pol J Pathol (2005) 0.75
[Prognostic significance of depth and mode of invasion of the neoplasm in the presence of micrometastases in laryngeal carcinoma--cytokeratin antigens expression in lymph nodes]. Pol Merkur Lekarski (2005) 0.75
Androgen receptor (AR) expression in normal and cancerous human endometrial tissues detected by RT-PCR and immunohistochemistry. Anticancer Res (2002) 0.75
[Molecular basis of gynecological oncology - TopBP1 protein as the guardian of genome integrity]. Ginekol Pol (2013) 0.75
Loss of heterozygosity in the RAD51 and BRCA2 regions in breast cancer. Cancer Detect Prev (2008) 0.75